Clinical Evaluation of Hepatocarcinogenesis and Outcome Using a Novel Glycobiomarker <i>Wisteria floribunda</i> Agglutinin-Positive Mac-2 Binding Protein (WFA<sup>+</sup>-M2BP) in Chronic Hepatitis C with Advanced Fibrosis

Takako Inoue(Kaneka (United States)), Yasuhito Tanaka(Kumamoto University), Kei Fujiwara(Nagoya City University), Yuji Tsuzuki(Nagoya City University Hospital), Noboru Shinkai(Nagoya City University), Etsuko Iio(Nagoya City University), Kentaro Matsuura(Nagoya City University), Kayoko Matsunami(Nagoya City University), Shunsuke Nojiri(Nagoya City University)
Japanese Journal of Infectious Diseases
January 1, 2018
10.7883/yoken.jjid.2017.459
Cited by 9

Related Papers

Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial
|Gut|2019|732
Cyclosporin A and Its Analogs Inhibit Hepatitis B Virus Entry Into Cultured Hepatocytes Through Targeting a Membrane Transporter, Sodium Taurocholate Cotransporting Polypeptide (NTCP)
|Hepatology|2013|259
Epidermal growth factor receptor is a host-entry cofactor triggering hepatitis B virus internalization
|Proceedings of the National Academy of Sciences|2019|241
Gut Dysbiosis Associated With Hepatitis C Virus Infection
|Clinical Infectious Diseases|2018|187
Interleukin-1 and Tumor Necrosis Factor-α Trigger Restriction of Hepatitis B Virus Infection via a Cytidine Deaminase Activation-induced Cytidine Deaminase (AID)
|Journal of Biological Chemistry|2013|166